ctrl K

Price Alert

Immuneering Corporation (IMRX)

NASDAQ: IMRX · Real-Time Price · USD

3.49

-0.27 (-7.18%)

At close: Aug 18, 2025, 3:59 PM

3.41

-2.29%

Pre-market: Aug 19, 2025, 04:22 AM EDT

Immuneering Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	36.15M	59.41M	72.64M	74.89M
Short-Term Investments	n/a	26.26M	32.89M	74.31M
Long-Term Investments	n/a	n/a	n/a	996.56K
Other Long-Term Assets	1.3M	1.03M	743.7K	102.13K
Receivables	n/a	n/a	12.42K	246.04K
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	3.44M	3.42M	3.21M	n/a
Total Current Assets	39.59M	89.08M	108.75M	152.33M
Property-Plant & Equipment	4.79M	5.4M	5.78M	6.13M
Goodwill & Intangibles	7.04M	7.07M	7.1M	7.14M
Total Long-Term Assets	13.13M	13.5M	13.62M	14.37M
Total Assets	52.71M	102.58M	122.37M	166.7M
Account Payables	1.96M	2.11M	3.15M	1.39M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	3.82M	3.89M	3.65M	2.92M
Total Current Liabilities	7.5M	7.85M	8.05M	5.63M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	3.82M	4.16M	4.46M	5.09M
Total Liabilities	11.33M	12.01M	12.52M	10.72M
Total Debt	4.16M	4.46M	4.84M	5.36M
Common Stock	31.05K	29.27K	26.42K	26.32K
Retained Earnings	-224.29M	-163.26M	-109.79M	-59.27M
Comprehensive Income	n/a	-778	-30.12K	-49.01K
Shareholders Equity	41.39M	90.58M	109.85M	155.98M
Total Investments	n/a	26.26M	32.89M	75.31M